This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Members of the Vermont House of Representatives gave initial approval today to legislation, Senate Bill 54 , regulating the commercial production and retail sale of marijuana to adults. In 2018, lawmakers approved legislation legalizing the personal possession and private cultivation of marijuana by those ages 21 and older.
Provisions in the bill permit adults to purchase (up to two ounces from state-licensed retailers and/or 8 grams of concentrate and 800 milligrams worth of edible products), home-cultivate (up to eight plants, no more than four of which can be mature), and possess cannabis (up to 2 pounds in private).
Lou Leon Guerrero signed legislation today legalizing the personal possession of marijuana by adults, and establishing regulations governing the plant’s commercial production and retail sale. The Act creates a new regulatory board to draft rules governing the plant’s commercial production and retail sale.
Senate Bill 686 seeks to legalize the use, possession, cultivation, and retail sale of small amounts of marijuana for adults. House Bill 481 seeks to allow for the use, possession, and retail sale of marijuana by adults. This bill does not allow for home cultivation or expungement of prior convictions. New Hampshire.
Recently, nuEra Cannabis announced its agreement to acquire Ieso , a licensed medical and adult-use cultivation facility located in Murphysboro, Illinois. The facility also boasts a fully operational extraction lab and an infusion operation, producing a full range of products, including vaporizers, concentrates, edibles, and more.
NV Green”), producers of best-in-class concentrates. Tahoe Hydro operates ~33,000 square feet of total cultivation and manufacturing space in its facilities in Carson City, Nevada, and Sparks, Nevada. We seek to be the largest scale cultivator of high-quality cannabis in every market where we operate. (CSE: AYR.A,
Prices of recreational weed are often a result of how long the state market has been around and how many cultivators it has operating. Since cultivators grow cannabis domestically in the U.S., For others working in cultivation and processing facilities, safety and health issues, along with long hours, often plague them.
New York City’s mayor has a bold plan to kick start cannabis cultivation, New Mexico got its first cannabis consumption lounge, and New Jersey finally opened its recreational cannabis market. What do you think of Eric Adams’ vision of cannabis cultivation in the Big Apple? Let’s dive into this week’s cannanews.
SAN FRANCISCO–( BUSINESS WIRE )– Eaze , the nation’s largest cannabis delivery marketplace, and multi-state retail leader Green Dragon are pleased to announce they have reached an agreement to provide service to customers and patients in California, Colorado, Michigan, and Florida. Eaze delivers good with the goods. With over 7.8
Retail sales of medical cannabis for March reached $22,108,115.88 Retail sales of medical cannabis for March totaled $10,816,859.45 in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries reached $2,311,940,075.94. in dry flower and $11,291,256.40
in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries reached $249,702,549.44. Total retail sales for 2024 reached $215,829,673.13. In September, Illinois dispensaries sold $10,516,825.48 in dry flower sales and $11,182,563.32 February: $24,427,904.62 May: $24,413,018.67
in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries reached $2,110,831,761.38. Total retail sales for 2024 reached $147,266,853.89. Total retail sales for 2024 reached $147,266,853.89. In June, Illinois dispensaries sold $11,112,600.33 February: $24,427,904.62
Legislation is pending, Senate Bill 420, permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. Send a message to your lawmakers in support of home cultivation rights. Legislation is pending, House Bill 1663, to allow for the use, possession, and retail sale of marijuana by adults.
Retail sales of medical cannabis for September included $10,720,347.63 in concentrates/infused products. Total 2024 retail sales by licensed medical cannabis dispensaries reached $238,039,128.10, and total retail sales since November 2015 by licensed medical cannabis dispensaries reached $2,201,604,035.58.
For 2024, retail sales by licensed medical cannabis dispensaries finished at $285,059,601.92. Retail sales of medical cannabis for December reached $23,486,395.69, including $11,100,270.52 in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries reached $2,248,624,394.40.
(the “Company” or “Decibel”) (TSX-V: DB) (OTCQB: DBCCF ), a premium cannabis producer, is pleased to announce the launch of its high-end concentrate brand, “ Pressed by Qwest “, and new dried flower, pre-roll, vape, and concentrate products. New Vape and Concentrate Products.
Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Eliminates the plant tagging system to tax plants cultivated for personal use. New Hampshire. RI resident? Update : S.54
in concentrates/infused products. in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries is $1,693,048,677.29. Total 2023 wholesale sales by cultivation centers reached $79,407,155.34. January 2023 totals included $12,650,256.16
This statement fails to consider cases where hemp or hemp products are shipped from a state that is different than the state of cultivation. Consider an online hemp retailer operating out of New York. The retailer has done her due diligence and has copies of each farmer’s license to cultivate hemp.
in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries reached $219,974,409.95. Total retail sales for 2024 reached $170,617,973.63. In July, Illinois dispensaries sold 11,151,118.24 in dry flower sales and $12,400,131.63 Monthly Totals for 2024: January: $24,338,551.30
in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries reached $249,702,549.44. Total retail sales for 2024 reached $194,130,227.26. In August, Illinois dispensaries sold $11,332,050.49 in dry flower sales and $12,180,708.64 February: $24,427,904.62 March: $25,917,010.11
CSE: FFNT ) ( OTCQX: FFNTF ) (“4Front” or the “Company”), a vertically integrated, multi-state cannabis operator and retailer, announced the first closing of a multiphase expansion project to build an up to 558,000 sq. cultivation and production facility (the “Facility”) in the Village of Matteson , Illinois, located outside of Chicago.
in concentrates/infused products. in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries totaled $2,012,330,727.38. Total retail sales for 2024 reached $48,765,439.01. In January, Illinois dispensaries sold $11,505,949.92 in dry flower sales and $12,832,601.38
Combined Operations Pair Eaze Delivery Expertise with Green Dragon Retail Operations Excellence, Expanding Consumer Access to Cannabis Across Four of the Fastest-Growing U.S. The combined company will operate 42 delivery and storefront retail locations and serve markets with a combined value of nearly $10 billion. With over 7.8
Retail sales of medical cannabis for November included $11,217,284.40 in concentrates/infused products. Total 2024 retail sales by licensed medical cannabis dispensaries reached $261,573,052.74, and total retail sales since November 2015 by licensed medical cannabis dispensaries reached $2,225,138,245.22.
This week, officials with the Alaska’s Marijuana Control Board issued their first-ever permits to retailers who wish to allow customers to consume cannabis on the premises. Legislation is pending, House Bill 1663, to allow for the use, possession, and retail sale of marijuana by adults. New Hampshire. Update : S.54 VT resident?
Craft grow changes include the repeal of provisions establishing cultivator taxes and craft grower taxes and a shared premises pilot program. The provision for the shared premises pilot program states, “The Department of Agriculture shall create a pilot program that shall allow craft growers to share premises with cultivation center.
in concentrates/infused products. Total 2023 retail sales by licensed medical cannabis dispensaries totaled $245,113,258.87. Total retail sales since November 2015 by licensed medical cannabis dispensaries totaled $1,883,888,326.90. Illinois dispensaries sold $12,487,157.03 in dry flower and $13,512,909.61 February: $26,652,042.97
in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries reached $2,063,314,235.32. Total retail sales for 2024 reached $99,749,327.83. In April, Illinois dispensaries sold $11,853,546.55 in dry flower sales and $13,213,427.59 February: $24,427,904.62 March: $25,917,010.11
Total 2023 retail sales by licensed medical cannabis dispensaries have totaled $271,357,790.69. in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries totaled $1,910,132,838.71. For the last four months, totals have hovered around $26 million.
in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries totaled $2,038,247,899.49. Total retail sales for 2024 reached $74,682,676.11. In March, Illinois dispensaries sold $12,245,278.55 in dry flower sales and $13,671,731.56 February: $24,427,904.62 March: $25,917,010.11
One key provision addresses the definition of “THC” and the total concentration level limits of 0.3% House Bill 5306 and Senate Bill 3790 , with identical wording, add a plethora of regulatory provisions to the Illinois Industrial Hemp Act and other Acts.
Start-up seedbanks, locally manufactured extraction companies, both CBD and THC oil companies, headshops, coffeeshops and even a cannabis dispensary retail store are now doing business in all major cities across the country. All of these cups had top-quality entries from local cultivators and processors. Cannabis Cups.
Concentrates/infused products accounted for $14,304,767.40 Total 2023 retail sales by licensed medical cannabis dispensaries totaled $192,656,615.58. Total 2023 retail sales by licensed medical cannabis dispensaries totaled $192,656,615.58. July 2023 medical cannabis sales totaled $26,844,669.58.
Retail sales of medical cannabis for December included $12,900,074.74 in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries totaled $1,963,567,712.76. Total retail sales since November 2015 by licensed medical cannabis dispensaries totaled $1,963,567,712.76.
And a North Dakota bill to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes was defeated in a Senate committee this week. Legislation is pending, House Bill 708, to legalize the use, possession, cultivation, and retail sale of small amounts of marijuana for adults. MO resident?
One key provision addresses the definition of “THC” and the total concentration level limits of 0.3% Stakeholders in the hemp industry are concerned that SB392’s broad language has been written so poorly that it could ban all hemp products, including CBD.
Retail sales of medical cannabis for March, similar to recreational sales, received a bounce in all categories. in concentrates/infused products. Total 2023 retail sales by licensed medical cannabis dispensaries totaled $83,291,336.62. March totals of $29,018,805.60 included $15,761,537.58 in dry flower sales and $14,970,766.26
in concentrates/infused products. Total 2023 retail sales by licensed medical cannabis dispensaries totaled $165,812,213.19. Total Retail Sales since November 2015 by Licensed Medical Cannabis Dispensaries totaled $1,804,587,711.21. June totals reached $27,027,872.42, including $12,785,438.69
in concentrates/infused products. Total 2023 retail sales by licensed medical cannabis dispensaries totaled $111,325,231.45. Total Retail Sales since November 2015 by Licensed Medical Cannabis Dispensaries totaled $1,750,100,794.48. April totals reached $28,034,031.49, including $12,872,834.64
in concentrates/infused products. Total 2023 retail sales by licensed medical cannabis dispensaries totaled $138,785,384.43. Total Retail Sales since November 2015 by Licensed Medical Cannabis Dispensaries totaled 1,777,560,947.45. May totals reached $27,461,289.64, including $12,871,999.91
Retail sales of medical cannabis for February slumped to $19,748,199.87, which was the lowest total since June 2019. in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries reached $2,289,831,974.06. February 2025 medical cannabis sales included $9,625,137.04
Cookies Top-Shelf Genetics Featured in New Lines of Concentrates and Cartridges Now Exclusively Available at Cookies Tacoma, Statewide to Follow. Washington cannabis consumers now have access to a full line of concentrates and cartridges featuring Cookies’ sought-after genetics such as Berry Pie, Pomello and Sweet Tea. TACOMA, Wash.–(BUSINESS
December’s retail sales included $14,255,331.28 in concentrates/infused products. Total retail sales since November 2015 by licensed medical cannabis dispensaries is $1,638,776,607.69. Total retail sales since November 2015 by licensed medical cannabis dispensaries is $1,638,776,607.69. and 2020 totals of $357,119,378.27.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content